Health Biotech Limited WHO-GMP
Health Biotech Limited
Health Biotech LimitedHealth Biotech Limited  
Health Biotech Limited Health Biotech Limited



pre-filled-syringes
Health Biotech Limited
Home - Oncology(Anti-Cancer-Injectables) - Cytosine Arabinoside Injection

Cytosine Arabinoside Injection

It is phosphorylated in the body to corresponding nucleotide, which inhibits DNA repair. Cytorabine is cell cycle specific and acts primarly during S phase. Its main use is to induce remission in acute leukemia.
Composition : 100mg/1ml, 500mg/5ml, 1000mg/10ml
Indications : Acute leukemias, lymphosarcomas.
Dosage: 3-6 mg/Kg body wt. i.v daily in 2 divided doses for 5-10 days.
Conraindications: Hypersensitivity, Pregnancy.
Special Precautions : Hepatic impairment.
Paediatrics : Indicated in certain leukemia, under strict supervision.
Pregnancy : Safety not established
Lactation : Safety not established
Elderly : Use with caution
Side- Effect : Bone marrow suppression. G.I.T disturbances.
Drug Interaction : Potentiates bone marrow depression with radiotheraphy and other myelotoxic drugs. Reduces plasma concentration of digoxin,antagonizes gentamycin. Decreased efficacy of flurocytosine.
Purity : Not less than 99%.
» Send Enquiry

Cytosine-Arabinoside-injection
Health Biotech Limited
Our Products
Oncology(Anti-Cancer-Injectables)  |  Pre-Filled Syringes  |  Antibiotics & Anti-Infectives  |  New Molecules (FDC)  |  Liquid Ampoules / Vials  |  Biological Injections
Cardiovascular Injections  |  Neurology  |  Other Injectables  |  Hormones  |  Eye/ Ear/ Nasal Drops  |  Liquid Syrups , Dry Syrups & Redi-Mix Syrups  |  Sildenafil Oral Jelly  |  Pharmaceutical Capsules  |  Pharmaceutical Tablets  |  Tablets and Capsule


Clicky Web Analytics